Table 4 Long-term outcomes of 150 patients

Tumor recurrence

n (%)

67 (44.7)

12 (75.0)

55 (41.0)

0.015

Hematogenous metastasis

n (%)

21 (14.0)

5 (31.3)

16 (11.9)

0.051

liver/bone/lung/brain/ovary/muscle/skin

17/2/2/2/1/1/1

4/0/0/1/0/1/0

13/2/2/1/1/0/1

-

Lymphatic metastasis

n (%)

15 (10.0)

3 (18.8)

12 (9.0)

0.203

regional/extra-regional

2*/14*

0/3

2*/11*

-

Peritoneal metastasis

n (%)

44 (29.3)

7 (43.8)

37 (27.6)

0.244

Outcomes within 5 years

alive/dead/unknown

78/59/13

4/11/1

74/48/12

0.038